SYNH Stock Recent News
SYNH LATEST HEADLINES
Syneos Health's (SYNH) share price movement is expected to be favorable due to the strength of the company's Syneos One portfolio and several value-added partnership deals.
MORRISVILLE, N.C., April 13, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, will release its first quarter 2023 financial results on Wednesday, May 10th, 2023, prior to its earnings call at 8:00 a.m. ET.
Dealreporter article says that multiple PE firms are bidding for the company and even named advisors the company has hired. Private equity math works given relatively low current leverage and high cash generation.
Syneos Health's (SYNH) partnership with KX is likely to accelerate clinical trial execution using AI-enabled solutions.
With the multi-year deal, Syneos Health (SYNH) aims to deliver technology and data solutions with Microsoft.
Syneos Health (SYNH) remains confident about the long-term strength of its business, given its robust backlog and unique market position.
Higher reimbursable expenses and growth in Deployment Solutions contribute to Commercial Solutions revenue growth at Syneos Health (SYNH).
Syneos Health, Inc. (NASDAQ:SYNH ) Q4 2022 Earnings Conference Call February 16, 2023 8:00 AM ET Company Participants Ronnie Speight - Senior Vice President, Investor Relations Michelle Keefe - Chief Executive Officer Jason Meggs - Chief Financial Officer Michael Brooks - Chief Operating Officer Conference Call Participants Patrick Donnelly - Citi David Windley - Jefferies Eric Coldwell - Baird Justin Bowers - Deutsche Bank Sandy Draper - Guggenheim Max Smock - William Blair Casey Woodring - JPMorgan Luke Sergott - Barclays Elizabeth Anderson - Evercore Operator Good morning, ladies and gentlemen. Welcome to the Syneos Health Fourth Quarter and Full Year 2022 Earnings Conference Call.
Syneos Health (SYNH) delivered earnings and revenue surprises of 4.24% and 5.47%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
MORRISVILLE, N.C., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its fourth quarter and full year 2022 financial results on Thursday, February 16, 2023, prior to its earnings call at 8:00 a.m. ET.